Parabilis Medicines, Inc. Common Stock (PBLS) — Working Capital to Net Assets Ratio
Parabilis Medicines, Inc. Common Stock (PBLS) has a Working Capital to Net Assets ratio of 101.4% as of June 2026. Working capital of $1.06 Billion (current assets of $1.13 Billion minus current liabilities of $62.84 Million) is measured against net assets of $1.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Parabilis Medicines, Inc. Common Stock Working Capital to Net Assets (2024–2025)
This chart shows how Parabilis Medicines, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 101.4%, reflecting working capital of $1.06 Billion against net assets of $1.05 Billion USD. See Parabilis Medicines, Inc. Common Stock defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Parabilis Medicines, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Parabilis Medicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Parabilis Medicines, Inc. Common Stock balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 166.0% | $-27.43 Million | $-16.52 Million | $29.36 Million | $56.79 Million | ▲ +60.1 pp |
| 2024 | 105.9% | $59.80 Million | $56.44 Million | $92.21 Million | $32.41 Million | — |